|Other Names||Rhabdoid tumor deletion region protein 1, RTDR1|
|Target/Specificity||The synthetic peptide sequence used to generate the antibody AP13240a was selected from the N-term region of RTDR1. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.|
|Format||Synthetic peptide was lyophilized with 100% acetonitrile and is supplied as a powder. Reconstitute with 0.1 ml DI water for a final concentration of 1 mg/ml.|
|Storage||Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C.|
|Precautions||This product is for research use only. Not for use in diagnostic or therapeutic procedures.|
|Tissue Location||Expressed in adult cerebellum, spinal cord, spleen, skeletal muscle and some/5 out of 9 rhabdoid tumors Detected in fetal brain, lung, liver and kidney|
email@example.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
This gene encodes a protein with no known function butwith slight similarity to a yeast vacuolar protein. The gene islocated in a region deleted in pediatric rhabdoid tumors of thebrain, kidney and soft tissues, but mutations in this gene have notbeen associated with the disease.
Gudbjartsson, D.F., et al. Nat. Genet. 40(5):609-615(2008)Barrios-Rodiles, M., et al. Science 307(5715):1621-1625(2005)Collins, J.E., et al. Genome Biol. 5 (10), R84 (2004) :Zhou, J., et al. Gene 241(1):133-141(2000)
If you have any additional inquiries please email technical services at firstname.lastname@example.org.